EPIPHARM AG has a total of 14 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Australia, Canada and Israel. Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are TIEFENBACHER ALFRED E GMBH & CO KG, BUKWANG PHARM CO LTD and UPSHER SMITH LABORATORIES LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Canada | 2 | |
#3 | Israel | 2 | |
#4 | Brazil | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | Singapore | 1 | |
#10 | United States | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Unspecified technologies | |
#5 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Sift Carter Rosemarie | 10 |
#2 | Rosemarie Sift Carter | 2 |
Publication | Filing date | Title |
---|---|---|
KR20160145818A | Treatment or prevention of seborrheic keratosis using artemisinin and derivatives thereof | |
AU2006303809A1 | Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |